Skip to content
“ALS is a devastating disease.” This is a common refrain when talking about Amyotrophic Lateral Sclerosis (ALS), a nervous system disease that weakens muscles […]
Unlocking hope: AMP ALS is transforming ALS biomarker research Read More »
Artificial intelligence (AI) is on everyone’s mind these days. In healthcare and biotech, AI is addressing some of the industry’s biggest challenges, as well
NIH Innovation Zone 2024: Modality.AI tackles remote neurological assessment Read More »
The COVID pandemic underscored the reality of medical inequity worldwide, a longstanding issue reflected in clinical trials, particularly regarding the absence of race and
BIO 2024: Can data improve clinical trial diversity? Read More »
Investing in women’s health is a gold mine that few healthcare investors have yet to tap, according to a new study that has come
BIO 2024: Investing in women’s health is an untapped gold mine Read More »
In August 2020, the World Health Organization (WHO) adopted a global strategy to eliminate cervical cancer in our lifetime. “To eliminate cervical cancer,” according
We can eliminate cervical cancer in our lifetime – here’s how Read More »
On June 7, the U.S. Food and Drug Administration (FDA) approved an expanded age indication for GSK’s Arexvy, making it the first respiratory syncytial
FDA approves Arexvy for patients 50–59 Read More »
With the passage of the Inflation Reduction Act (IRA) and the growing number of prescription drug affordability boards (PDABs), patients and the biotech industry
BIO 2024: PDABs and IRA pose a murky threat to patient access Read More »
The Biotechnology Innovation Organization (BIO), in partnership with Korn Ferry, released the 2024 DEI report, Charting a Path to Inclusive Excellence for Biotechnology Companies,
Survey: DEI is good for business, but improvements are needed Read More »
“Biotechnology, that’s a great, big word that just means hope.” That’s what Christopher Reeve said years ago at a BIO International Convention. Little did
Admiral William H. McRaven and BIO CEO John F. Crowley talk hope in biotech Read More »
Viola Davis is a world-renowned actress, writer, and producer, holding the coveted EGOT status in Hollywood (winning an Emmy, Grammy, Oscar, and two Tony
BIO 2024: Viola Davis and Aaron Lazar share lessons on life and legacy Read More »
